ICD-10 N30.10 is officially defined as "Interstitial cystitis (chronic) without hematuria." code N30.10 is referenced in 6 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code N30.10 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Aetna considers broth culture testing for interstitial cystitis experimental, investigational, or unproven because there is inadequate evidence of its effectiveness in diagnosing and managing the condition. Interstitial cystitis (chronic), ICD-10 N30.10 and N30.11, is listed as an indication that is not covered. Related urine culture codes are CPT 87086 and 87088 and HCPCS P7001.
Aetna considers cannabinoids, hypnotherapy, hypogastric plexus neurolysis for chronic pelvic pain associated with endometriosis, neuromodulation (dorsal root ganglion stimulation, posterior tibial nerve stimulation, sacral nerve stimulation, and spinal cord stimulation), peritoneal excision (stripping) for endometriosis, and superior hypogastric plexus block with traditional pharmacological treatments experimental, investigational, or unproven. Uterine nerve ablation, laparoscopic uterine nerve ablation and presacral neurectomy are also considered experimental, investigational, or unproven for chronic pelvic pain or other indications. The policy lists related CPT and HCPCS codes, and endometriosis ICD-10 codes, as not covered for the indications it names.
Cannabinoids, hypnotherapy, hypogastric plexus neurolysis for chronic pelvic pain associated with endometriosis, neuromodulation (dorsal root ganglion stimulation, posterior tibial nerve stimulation, sacral nerve stimulation, and spinal cord stimulation), peritoneal excision (stripping) for endometriosis, superior hypogastric plexus block with traditional pharmacological treatments, and uterine nerve ablation, laparoscopic uterine nerve ablation and presacral neurectomy for chronic pelvic pain or other indications are considered experimental, investigational, or unproven because their effectiveness has not been established. The policy lists CPT codes not covered for the indications it lists, including neurostimulator implantation, revision, removal and programming codes, superior hypogastric plexus injection code 64517, and hypnotherapy code 90880, along with ICD-10 diagnosis codes not covered for those indications. Peritoneal excision (stripping) has no specific code in this policy.
Aetna considers broth culture testing for interstitial cystitis experimental, investigational, or unproven, because there is inadequate evidence of the effectiveness of this test in the diagnosis and management of interstitial cystitis. The diagnosis of interstitial cystitis is primarily one of exclusion, made from the combination of symptoms, cystoscopic findings, and bladder biopsies. Related codes include CPT 87086, 87088 and 87181-87190 and HCPCS P7001, and ICD-10 codes N30.10 and N30.11 for interstitial cystitis are not covered for the indications listed.
Aetna clinical policy bulletin 0805 considers pudendal nerve decompression experimental, investigational, or unproven for indications including chronic pelvic pain, interstitial cystitis, penile numbness and erectile dysfunction, persistent genital arousal disorder, pudendal neuralgia, and vulvodynia. The policy also considers pudendal nerve hydrodissection for chronic pelvic pain syndrome and urinary incontinence, and pudendal neurolysis for persistent genital arousal disorder and pudendal nerve entrapment syndrome, experimental, investigational, or unproven. The policy does not apply to pudendal nerve blocks used in obstetrics and other operative procedures.
Aetna's clinical policy bulletin 0805 on pudendal nerve decompression was reviewed on 10/28/2026. It treats pudendal nerve decompression, hydrodissection and neurolysis as experimental, investigational or unproven for chronic pelvic pain, pudendal neuralgia, interstitial cystitis, penile numbness and erectile dysfunction, persistent genital arousal disorder and vulvodynia, and it lists three related CPT codes as not covered for those indications. The source does not state an effective date for a change or describe a coverage change in this review.
Watch N30.10
Get one email when a payer policy names N30.10, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.